window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 17, 2026

  • News
  • About Us
Contact Us

Pharma Innovation

  • CDMOs & Manufacturing,Drug Development,Events and Conferences,Pharmaceuticals and therapeutics,Supply Chain & Logistics

    CPhI & PMEC India 2025 showcases pharma innovation and sets stage for expanded 2026 edition

    The 18th edition of CPhI & PMEC India, South Asia’s [...]

    January 12, 2026
  • Artificial Intelligence,Clinical Trials,Digital Health,Drug Development,Global health,Partnerships & Funding,Pharmaceuticals and therapeutics,Technology and platforms

    QuantHealth secures strategic investment from Sanofi Ventures to accelerate AI-driven clinical trials

    QuantHealth, a pioneer in AI-driven clinical trial simulation, has received [...]

    October 1, 2025
  • CDMOs & Manufacturing,Drug Development,Market Access & Commercialization,Partnerships & Funding,Supply Chain & Logistics,Technology and platforms,Uncategorised

    CPHI Frankfurt 2025 set to welcome more than 60,000 global pharma professionals

    CPHI Frankfurt 2025 will bring the world’s pharmaceutical community back [...]

    September 11, 2025
  • Artificial Intelligence,Clinical Development,Drug Development,Market Access & Commercialization,Research & Development,Technology and platforms

    Pharma’s AI tipping point: C-suite leaders move from pilots to enterprise scale

    The pharmaceutical sector is accelerating into an enterprise-scale AI future, [...]

    July 18, 2025
  • Artificial Intelligence,CDMOs & Manufacturing,Drug Development,Technology and platforms

    AI can’t thrive in chaos: New survey finds labs still struggling with basics

    A new industry survey has revealed that while life sciences [...]

    June 27, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Cell & Gene Therapy,Partnerships & Funding,Regulatory Affairs

    Unlocking collective intelligence: Why cell and gene therapy needs a data-sharing revolution

    Alexander Seyf, CEO of Autolomous, explains how collaboration—not competition—is the [...]

    June 10, 2025
  • CDMOs & Manufacturing

    Vetter named best managed company for sixth year

    Vetter, the Germany-based contract development and manufacturing organisation (CDMO), has [...]

    May 27, 2025
  • Artificial Intelligence,Clinical Trials

    PhaseV raises $50M to expand AI-powered clinical trial platform

    PhaseV has secured $50 million in Series A funding to [...]

    May 13, 2025
  • CDMOs & Manufacturing,Partnerships & Funding,Technology and platforms

    Colorcon and ASHA Cellulose partner to advance barrier membrane technologies for pharma and nutra formulations

    Colorcon, a specialist in film coatings, excipients, and controlled release [...]

    May 8, 2025
  • Clinical Trials,Patient Centricity

    Pharma giants eye obesity trial boom — but are they ready for what comes next?

    May 7, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Veristat names Kim McLean Boericke as CEO to drive next phase of clinical research growtheristat names Kim McLean Boericke as CEO to drive next phase of clinical research growth
    Categories: Biotech, Clinical Development, Clinical studies, Clinical Trials, Healthcare leadership, Movers & Shakers, Rare Diseases
  • Will Edwards appointed CEO as Astoriom expands international storage and biorepository operations
    Categories: Biomanufacturing, CDMOs & Manufacturing, Healthcare leadership, Movers & Shakers, Pharmaceuticals and therapeutics
  • CombinAbleAI to be acquired by insitro to expand AI drug discovery platform
    Categories: Artificial Intelligence, Biotech, Drug Development, Mergers & Acquisitions, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top